Lu-AG22515

N/A

Report date: 2025/05/13 15:10:30

Base Information

Drug NameLu-AG22515
Drug Alias NameAPB-A1Lu-AG22515
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionAnti-CD40 ligand
TargetsCD40 ligand
Therapy Area/IndicationsGraves OphthalmopathyNeuromyelitis Optica
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryBosnia and HerzegovinaBulgariaUnited States +[5
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAprilBio Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsGraves OphthalmopathyNeuromyelitis Optica
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A